Added therapeutic benefit regarding ESMO-MCBS and the French health technology assessment of drugs granted early access program.
作者信息
Pham F Y-V, Jacquet E, Monard A, Brunel L, Blay J-Y, Albin N
机构信息
Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products, Saint-Denis, France; Department of Pharmacy, Centre hospitalo-universitaire Hôpital Henri Mondor Assistance Publique des Hôpitaux de Paris, Créteil, France.
Department of Oncohematology, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France.
出版信息
Ann Oncol. 2022 May;33(5):561-563. doi: 10.1016/j.annonc.2022.02.002. Epub 2022 Feb 14.
PMID:35176459
Abstract
摘要
Zotero 插件